Hyponatremia Treatment Options: Management of High-Risk Patients

Title:

Hyponatremia Treatment Options: Management of High-Risk Patients

Topic: Nephrology
Relevant Terms: Hyponatremia
Primary Audience: Primary Care Physicians
Launch Date: 30-Apr-13
Credits: AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Patients Seen:  Nathan Janet
Curriculum Name: Optimizing Treatment for Hyponatremia

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Analyze the therapeutic options available to treat hyponatremia in hospitalized patients
  2. Describe when various therapeutic options should be utilized in the treatment of hyponatremia
  3. Discuss the risks and benefits of the therapeutic options for the treatment of hyponatremia

    Faculty

    Mitchell H. Rosner, MD, FACP
    Chairman, Department of Medicine
    Henry B. Mulholland Professor of Medicine
    University of Virginia Health System
    Charlottesville, VA
    Michael J. Cawley, BS, PharmD, RRT, CPFT
    Professor of Clinical Pharmacy
    Philadelphia College of Pharmacy
    University of the Sciences
    Philadelphia, PA
    DISCLOSURE POLICY STATEMENT
    The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
     
    All persons in a position to control the content of a continuing medical education program sponsored by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME, as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.
     
    The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
     
    FACULTY AND NON-FACULTY DISCLOSURES
    Dr. Cawley has served as a speaker for Abbott, Amgen, Bristol-Myers Squibb, Biogen Idec, Centocor, Genentech, Lilly, Novartis, Pfizer, and UCB
     
    Dr. Rosner has served as a consultant for Abbott Immunology, Alder, Amgen Corporation, AstraZeneca, Biotest, Bristol-Myers Squibb, Celgene, Centocor, Chelsea, Genentech, GlaxoSmithKline, Incyte, Lexicon Genetics, Lilly, Medimmune, MerckSerono, Novartis, NovoNordisk, Pfizer, Regeneron, Rigel, Sanofi-Aventis, and UCB.
     
    Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests: Barry Watkins, PhD; Bradley Pine; Blair St. Amand; Jay Katz, CCMEP; Dana Simpler, MD: Nothing to disclose 
     
    DISCLOSURE OF CONFLICT OF INTEREST
    The Potomac Center for Medical Education (PCME) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PCME for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
     
    DISCLOSURE OF UNLABELED USE
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Potomac Center for Medical Education (PCME) does not recommend the use of any agent outside of the labeled indications. 
     
    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    CREDIT DESIGNATION
    The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    ACCREDITATION STATEMENT
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    For more information about the accreditation of this program, please email contact@potomacme.org. 
     
    HOW TO RECEIVE CREDIT
    In order to obtain credit for this activity, participants must complete and submit the activity evaluation and post-test. Participants must earn a score of 60% or higher in order to pass the post-test. Certificates of credit will be available to print from your user history page.
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score with a 60% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
    There is no fee to participate in this activity.
     
    COURSE VIEWING REQUIREMENTS
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac
     
    Release Date: April 30, 2013
    Expiration Date: April 29, 2014

    COMMERCIAL SUPPORT
    This program is supported through an educational grant from Otsuka America Pharmaceutical, Inc.
    This continuing medical education activity is jointly sponsored by the and